Erratum: Repurposing cryptosporidium inosine 5′-Monophosphate dehydrogenase inhibitors as potential antibacterial agents (ACS Medicinal Chemistry Letters (2014) 5:8 (846-850) DOI: 10.1021/ml500203p);Repurposing cryptosporidium inosine 5′-monophosphate dehydrogenase inhibitors as potential antibacterial agents

ACS Medicinal Chemistry Letters

Volumn 5, Issue 8, 2014, Pages 846-850

  Mandapati, Kavitha ^a   Gorla, Suresh Kumar ^a   House, Amanda L ^b   McKenney, Elizabeth S ^b   Zhang, Minjia ^a   Rao, Suraj Nagendra ^a   Gollapalli, Deviprasad R ^a   Mann, Barbara J ^a,b   Goldberg, Joanna B ^b,d   Cuny, Gregory D ^c   Glomski, Ian J ^b   Hedstrom, Lizbeth ^a  

^a BRANDEIS UNIVERSITY   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF HOUSTON   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

antibacterial; antibiotic; Gram positive; IMP dehydrogenase; inhibitor

Indexed keywords

ANTIBIOTIC AGENT; CYSTATHIONINE BETA SYNTHASE; INOSINATE DEHYDROGENASE INHIBITOR;

ARTICLE; BACILLUS ANTHRACIS; BACTERIAL GROWTH; COMPETITIVE INHIBITION; CRYPTOSPORIDIUM PARVUM; DRUG BINDING SITE; DRUG TARGETING; ENZYME INHIBITION; HYDROGEN BOND; IC 50; LISTERIA MONOCYTOGENES; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION;

EID: 84906241587     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml500360x     Document Type: Erratum

References (18)

1. Bassetti, M.; Merelli, M.; Temperoni, C.; Astilean, A. New antibiotics for bad bugs: where are we? Ann. Clin. Microbiol. Antimicrob. 2013, 12, 22
2. Centers for Disease Control and Prevention (CDC). Antibiotic resistance threats in the United States, 2013; CDC: Atlanta, GA, 2013. Available from: http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508. pdf.
3. Hedstrom, L.; Liechti, G.; Goldberg, J. B.; Gollapalli, D. R. The antibiotic potential of prokaryotic IMP dehydrogenase inhibitors Curr. Med. Chem. 2011, 18, 1909-1918
4. Chen, L.; Wilson, D. J.; Xu, Y.; Aldrich, C. C.; Felczak, K.; Sham, Y. Y.; Pankiewicz, K. W. Triazole-linked inhibitors of inosine monophosphate dehydrogenase from human and Mycobacterium tuberculosis J. Med. Chem. 2010, 53, 4768-4778
5. Usha, V.; Hobrath, J. V.; Gurcha, S. S.; Reynolds, R. C.; Besra, G. S. Identification of novel Mt-Guab2 inhibitor series active against M. tuberculosis PLoS One 2012, 7, e33886
6. Rao, V. A.; Shepherd, S. M.; Owen, R.; Hunter, W. N. Structure of Pseudomonas aeruginosa inosine 5′-monophosphate dehydrogenase Acta Crystallogr., Sect. F: Struct. Biol. Cryst. Commun. 2013, 69, 243-247
7. Umejiego, N. N.; Gollapalli, D.; Sharling, L.; Volftsun, A.; Lu, J.; Benjamin, N. N.; Stroupe, A. H.; Riera, T. V.; Striepen, B.; Hedstrom, L. Targeting a prokaryotic protein in a eukaryotic pathogen: identification of lead compounds against cryptosporidiosis Chem. Biol. 2008, 15, 70-77
8. Maurya, S. K.; Gollapalli, D. R.; Kirubakaran, S.; Zhang, M.; Johnson, C. R.; Benjamin, N. N.; Hedstrom, L.; Cuny, G. D. Triazole inhibitors of Cryptosporidium parvum inosine 5′-monophosphate dehydrogenase J. Med. Chem. 2009, 52, 4623-4630
9. Sharling, L.; Liu, X.; Gollapalli, D. R.; Maurya, S. K.; Hedstrom, L.; Striepen, B. A screening pipeline for antiparasitic agents targeting Cryptosporidium inosine monophosphate dehydrogenase PLoS Negl. Trop. Dis. 2010, 4, e794
10. Macpherson, I. S.; Kirubakaran, S.; Gorla, S. K.; Riera, T. V.; D'Aquino, J. A.; Zhang, M.; Cuny, G. D.; Hedstrom, L. The structural basis of Cryptosporidium -specific IMP dehydrogenase inhibitor selectivity J. Am. Chem. Soc. 2010, 132, 1230-1231
11. Kirubakaran, S.; Gorla, S. K.; Sharling, L.; Zhang, M.; Liu, X.; Ray, S. S.; Macpherson, I. S.; Striepen, B.; Hedstrom, L.; Cuny, G. D. Structure-activity relationship study of selective benzimidazole-based inhibitors of Cryptosporidium parvum IMPDH Bioorg. Med. Chem. Lett. 2012, 22, 1985-1988
12. Gorla, S. K.; Kavitha, M.; Zhang, M.; Liu, X.; Sharling, L.; Gollapalli, D. R.; Striepen, B.; Hedstrom, L.; Cuny, G. D. Selective and potent urea inhibitors of Cryptosporidium parvum inosine 5′-monophosphate dehydrogenase J. Med. Chem. 2012, 55, 7759-7771
13. Johnson, C. R.; Gorla, S. K.; Kavitha, M.; Zhang, M.; Liu, X.; Striepen, B.; Mead, J. R.; Cuny, G. D.; Hedstrom, L. Phthalazinone inhibitors of inosine-5′-monophosphate dehydrogenase from Cryptosporidium parvum Bioorg. Med. Chem. Lett. 2013, 23, 1004-1007
14. Gorla, S. K.; Kavitha, M.; Zhang, M.; Chin, J. E.; Liu, X.; Striepen, B.; Makowska-Grzyska, M.; Kim, Y.; Joachimiak, A.; Hedstrom, L.; Cuny, G. D. Optimization of benzoxazole-based inhibitors of Cryptosporidium parvum inosine 5′-monophosphate dehydrogenase J. Med. Chem. 2013, 56, 4028-4043
15. Striepen, B.; Pruijssers, A. J.; Huang, J.; Li, C.; Gubbels, M. J.; Umejiego, N. N.; Hedstrom, L.; Kissinger, J. C. Gene transfer in the evolution of parasite nucleotide biosynthesis Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 3154-3159
16. Gollapalli, D. R.; Macpherson, I. S.; Liechti, G.; Gorla, S. K.; Goldberg, J. B.; Hedstrom, L. Structural determinants of inhibitor selectivity in prokaryotic IMP dehydrogenases Chem. Biol. 2010, 17, 1084-1091
17. O'Shea, R.; Moser, H. E. Physicochemical properties of antibacterial compounds: implications for drug discovery J. Med. Chem. 2008, 51, 2871-8
18. Morrison, J. F. Kinetics of reversible inhibition of enzyme catalyzed reactions by tight binding inhibitors Biochim. Biophys. Acta 1969, 185, 269-286